KR7005690003
KR7005690003
Pharmicell
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 771.65B EUR | 816.65B EUR | 961.26B EUR | 871.86B EUR |
Enterprise Value | 582.49B EUR | 827.14B EUR | 958.89B EUR | 857.59B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | 17.55x | 22.08x | 27.39x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 32.23x | 6.01x | 7.77x | 10.02x |
Price to Book | -- | 5.7x | 7.24x | 7.04x |
EV/Revenue | 24.33x | 6.08x | 7.75x | 9.85x |
EV/EBITDA | -94.18x | 17.34x | 22.47x | 29.78x |
Price to FCF (P/FCF) | -- | 31.3x | 30.09x | 25.13x |
EV/FCF | -- | 31.7x | 30.01x | 24.72x |
FCF Yield | -0.75% | 3.19% | 3.32% | 3.98% |